Cargando…
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
SIMPLE SUMMARY: Pancreatic cancer is difficult to treat. Novel treatment strategies are urgently needed to improve the survival rate, which is approximately 10% five years after diagnosis. The use of nanomedicines, which are formulated within a characteristic size range that favors its specific deli...
Autores principales: | Tanaka, Hiroyoshi Y., Nakazawa, Takuya, Enomoto, Atsushi, Masamune, Atsushi, Kano, Mitsunobu R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913712/ https://www.ncbi.nlm.nih.gov/pubmed/36765684 http://dx.doi.org/10.3390/cancers15030724 |
Ejemplares similares
-
Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment
por: Tanaka, Hiroyoshi Y., et al.
Publicado: (2018) -
Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment
por: Sun, Bo, et al.
Publicado: (2020) -
Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancer
por: Hamada, Shin, et al.
Publicado: (2013) -
Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines
por: Tang, Yufu, et al.
Publicado: (2022) -
Roadmap and strategy for overcoming infusion reactions to nanomedicines
por: Szebeni, Janos, et al.
Publicado: (2018)